임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

60건 표시 (상위 60건)

1상모집 예정· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers
리드: 한미약품
상세 →NCT07297693
1상모집 중· Obesity
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
리드: 한미약품
상세 →NCT07219589
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
상세 →NCT06724016
1상완료· Healthy
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
리드: 한미약품
상세 →NCT06518122
1상완료· Obesity
A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
리드: 한미약품
상세 →NCT06481098
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
리드: 한미약품
상세 →NCT06357910
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
리드: 한미약품
상세 →NCT06346184
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
상세 →NCT06234397
1상완료· Healthy Volunteers
A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
리드: 한미약품
상세 →NCT05862090
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers
리드: 한미약품
상세 →NCT05737082
1상완료· Healthy
A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
리드: 한미약품
상세 →NCT05723549
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
리드: 한미약품
상세 →NCT05598151
1상완료· Renal Impairment
Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
리드: 한미약품
상세 →NCT05711381
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
리드: 한미약품
상세 →NCT05548543
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
리드: 한미약품
상세 →NCT05548387
1상완료· Healthy
A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
리드: 한미약품
상세 →NCT05481307
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
리드: 한미약품
상세 →NCT05407220
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
리드: 한미약품
상세 →NCT05155995
1상완료· Healthy
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
리드: 한미약품
상세 →NCT05191563
1상완료· Healthy Volunteer
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
리드: 한미약품
상세 →NCT04975711
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008
리드: 한미약품
상세 →NCT04946903
1상완료· Healthy Adult Volunteer
Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers
리드: 한미약품
상세 →NCT04967014
1상완료· Atrial Fibrillation
The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
리드: 한미약품
상세 →NCT04764201
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
리드: 한미약품
상세 →NCT04762407
1상완료· Healthy Volunteer
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
리드: 한미약품
상세 →NCT04324905
1상완료· Healthy Volunteer
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
리드: 한미약품
상세 →NCT04204629
1상완료· Pharmacology
Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects
리드: 한미약품
상세 →NCT04076293
1상완료· Obese With Comorbidities
Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
리드: 한미약품
상세 →NCT04167553
1상완료· Health, Subjective
A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects
리드: 한미약품
상세 →NCT04081857
1상완료· Heathy Volunteer
Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects
리드: 한미약품
상세 →NCT03882112
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects
리드: 한미약품
상세 →NCT04084184
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
리드: 한미약품
상세 →NCT03826641
1상완료· Healthy
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
리드: 한미약품
상세 →NCT04322266
1상완료· Healthy
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.
리드: 한미약품
상세 →NCT04084197
1상완료· NAFLD
A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
리드: 한미약품
상세 →NCT03744182
1상완료· Health, Subjective
A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects
리드: 한미약품
상세 →NCT04087525
1상완료· Pharmacology
A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects
리드: 한미약품
상세 →NCT04032782
1상완료· Healthy
A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.
리드: 한미약품
상세 →NCT04081844
1상완료· Obesity
A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
리드: 한미약품
상세 →NCT03374241
1상조기 종료· Non Small Cell Lung Cancer
Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI
리드: 한미약품
상세 →NCT04510415
1상상태 미확인· Healthy
Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations
리드: 한미약품
상세 →NCT03372850
1상조기 종료· Type 2 Diabetes Mellitus
Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
리드: 한미약품
상세 →NCT03332836
1상완료· Healthy Volunteers
Molar Potency Study of HM12460A in Healthy Subjects
리드: 한미약품
상세 →NCT03330314
1상완료· Healthy
PK and Safety Study of HCP1102, HGP0813 and HGP1408
리드: 한미약품
상세 →NCT03371849
1상상태 미확인· Locally Advanced Solid Tumor
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
리드: 한미약품
상세 →NCT03284502
1상완료· Solid Tumor
Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers
리드: 한미약품
상세 →NCT03118817
1상완료· Healthy Male Volunteers
Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501
리드: 한미약품
상세 →NCT03089112
1상완료· Hyperlipidemias
Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers
리드: 한미약품
상세 →NCT02941796
1상완료· Overactive Bladder
Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers
리드: 한미약품
상세 →NCT02940314
1상완료· Erectile Dysfunction
PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers
리드: 한미약품
상세 →NCT02715401
1상완료· Healthy
Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers
리드: 한미약품
상세 →NCT02529800
1상완료· Healthy
Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers
리드: 한미약품
상세 →NCT04252872
1상완료· Healthy
Evaluating the Bioequivalence of HIP1302, HGP1406
리드: 한미약품
상세 →NCT02545829
1상상태 미확인· Type1 Diabetes Mellitus
Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
리드: 한미약품
상세 →NCT03332849
1상완료· Healthy
Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816
리드: 한미약품
상세 →NCT02554136
1상완료· Erectile Dysfunction
Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers
리드: 한미약품
상세 →NCT02712411
1상완료· Healthy
Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions
리드: 한미약품
상세 →NCT02941731
1상완료· Healthy
Evaluating the Bioequivalence of HIP1403, HGP0919
리드: 한미약품
상세 →NCT02473900
1상완료· Healthy Subjects
Molar Potency Study of HM12470 in Healthy Subjects
리드: 한미약품
상세 →NCT03330327
1상완료· Healthy
Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers
리드: 한미약품
상세 →NCT04039724

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.